News (340)

Sekisui Chemical : Notice of the 102nd Annual General Meeting of Shareholders PU
Sony : Current Report Of Foreign Issuer - Form 6-K PU
Sony : Director Appointments PU
Sony Group Corporation Director and Executive Appointments AQ
Astellas Pharma : Changes of Representative Director and Directors PU
Sony : Director and Executive Appointments PU
Astellas Pharma Inc. : - Change of Directors AQ
Astellas Pharma : Change of Directors PU
Sony : Selection of Board Member Candidates (PDF) PU
Astellas Pharma Inc. : - Change of Directors and Organizational Change AQ
Sony : Presentation slides PU
Sony : Executive Appointments PU
Sony : Selection of Board Member Candidates PU
Seattle Genetics : and Astellas Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer BU
Seattle Genetics : Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer PR
Pfizer : U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC) BU
Astellas Pharma : Launches Global Campaign in Collaboration with CNN as Part of Global Corporate Brand Activity (pdf 257KB) PU
Astellas Pharma : Acquires Universal Cells, Inc. (pdf 178KB) PU
Astellas Pharma : Partners with Discovery Communications for its Global Branding Campaign (pdf 484KB) PU
Astellas Acquires Universal Cells, Inc. PR
Astellas Pharma : Announce Top-Line Results for Two Phase 3 Trials of Peficitinib in Rheumatoid Arthritis Patients with Inadequate Response to Existing Therapy(pdf 249 KB) PU
Pfizer : Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer BU
Astellas Pharma : Announces Changes in Management Structure, Global Function, and Top Management Committees (pdf 200KB) PU
Astellas Pharma : Announces Personnel Changes and Organizational Changes (pdf 305KB) PU
Astellas Pharma Inc. Announces Board Changes; Effective Date from April 1, 2018 CI
Astellas Pharma : Announces Transition to a Company with an Audit & Supervisory Committee (pdf 242KB) PU
Astellas Pharma : Announces Acquisition of Own Shares (pdf 119KB) PU
Astellas Pharma : Reports Financial Results for the First Nine Months of FY2017 (pdf 145KB) PU
Astellas Pharma : Reports Financial Results for the First Nine Months of FY2017 BU
Astellas Pharma : Completes Acquisition of Mitobridge, Inc. (pdf 242KB) PU
Astellas Completes Acquisition of Mitobridge, Inc. PR
Astellas Pharma : Receives Orphan Designation from the European Commission for Gilteritinib for the Treatment of Acute Myeloid Leukaemia (pdf 377KB) PU
Astellas Pharma : and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients (pdf 359KB) PU
Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients GL
Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients PR
Astellas Pharma : Repatha® SC Injection 420 mg Auto Mini Doser Launched in Japan (pdf 583KB) PU
Astellas Pharma : Submits Supplemental New Drug Application for Approval of Additional Indication of Selective SGLT2 Inhibitor Ipragliflozin L-Proline for Patients with Type 1 Diabetes Mellitus in Japan PU
Transcript : Astellas Pharma Inc. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-09-2018 09:30 AM
Astellas Pharma : Application for Marketing Approval Submitted for Bispecific CD19-directed CD3 T Cell Engager (BiTE®) Antibody Construct Blinatumomab for Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia in Japan (pdf 205KB) PU
Astellas Pharma : to Present at J.P. Morgan Healthcare Conference (pdf 178KB) PU
Astellas Pharma : Announces First Clinical Data from Phase I Study of Gilteritinib in Combination with Intensive Chemotherapy in Patients Newly Diagnosed with Acute Myeloid Leukemia PU
Astellas Pharma : , the Institute of Medical Science of the University of Tokyo, Chiba University, and Asahi Kogyosha Enter into Collaborative Research Agreement on Rice-based Oral Vaccine "MucoRice" PU
Astellas Pharma : Announces Personnel Change(pdf 155KB) PU
Astellas Pharma : Acquires Mitobridge Under Existing Collaboration(pdf 359KB) PU
Astellas Acquires Mitobridge Under Existing Collaboration PR
1234NextSee all

Insiders

Picture Yoshihiko Hatanaka
Yoshihiko Hatanaka

Currently, Yoshihiko Hatanaka is Chairman of Astellas Pharma, Inc. He is also on the board of Sony Corp. In his past career he occupied the position of Chairman & Chief Executive Officer of Astellas Pharma US, Inc., President & Chief Executive Officer at Astellas US LLC and Director-Corporate Planning at Fujisawa Pharmaceutical Co., Ltd. He received an undergraduate degree from the University of Hitotsubashi.


Picture Yoshihiko Katsukawa
Yoshihiko Katsukawa

Yoshihiko Katsukawa is currently the President & Representative Director at Kobe Steel, Ltd.


Picture Yoshihiko Miyauchi
Yoshihiko Miyauchi

Yoshihiko Miyauchi is on the board of Access Co., Ltd. and 5 other companies. Mr. Miyauchi previously was Senior Chairman at ORIX Corp. He received an undergraduate degree from Kwansei Gakuin University and an MBA from the University of Washington.


Picture Yoshihiko Kawamura
Yoshihiko Kawamura

Mr. Yoshihiko Kawamura is a Chief Financial Officer at Hitachi Ltd. He is on the Board of Directors at IT Frontier Corp. Mr. Kawamura was previously employed as an Executive Officer by Mitsubishi Corp.


Picture Hisato Hatanaka
Hisato Hatanaka

Mr. Hisato Hatanaka is Managing Executive Officer at Ichiyoshi Securities Co., Ltd.



Picture Hideaki Hatanaka
Hideaki Hatanaka

Hideaki Hatanaka is currently a Senior Executive Officer at Tsuburaya Fields Holdings, Inc.





Picture Akihiro Hatanaka
Akihiro Hatanaka

Akihiro Hatanaka is the founder of The Four-Dimensional Group, Inc. (founded in 2005), Four-Dimensional Data, Inc. (founded in 2000), and Questetra, Inc. (founded in 2008).
He holds the title of Chief Technology Officer at the first two companies and Director & Chief Technology Officer at Questetra, Inc. Mr. Hatanaka received his undergraduate and graduate degrees from Kyoto University in 1998 and 2000, respectively.



Picture Toshikatsu Hatanaka
Toshikatsu Hatanaka

Toshikatsu Hatanaka worked as a Senior Corporate Auditor at The Kansai Electric Power Co., Inc. from 1974 to 2011.






Picture Shizuo Hatanaka
Shizuo Hatanaka

Shizuo Hatanaka worked at Maruichi Co., Ltd.
from 2011 to 2019.
He held the position of Independent Outside Director from 2016 to 2019.







Picture Eiji Hatanaka
Eiji Hatanaka

Eiji Hatanaka is currently working as an Executive Vice President for Corporate Development and Compliance at Certis USA LLC.


Picture Keiji Hatanaka
Keiji Hatanaka

Mr. Keiji Hatanaka is a Director & Deputy General Manager at Yulon Nissan Motor Co., Ltd.
He is on the Board of Directors at Yulon Nissan Motor Co., Ltd.
He received his graduate degree from Kyushu University.



Picture Norizaku Hatanaka
Norizaku Hatanaka

Norizaku Hatanaka is currently the Chairman at Sokuwa Co.,Ltd.
and an Independent Director at Formosa Sumco Technology Corp.
He obtained an undergraduate degree from Tenri University.


Picture Kazuhiro Hatanaka
Kazuhiro Hatanaka

Kazuhiro Hatanaka is currently working as a Senior Executive Officer & GM-Corporate Support at Shionogi & Co., Ltd.





Picture Kazuhiko Hatanaka
Kazuhiko Hatanaka

Kazuhiko Hatanaka is currently working as the Representative Director & Head-Finance at NTT Urban Development Corp.









Picture Haruhiko Hatanaka
Haruhiko Hatanaka

Haruhiko Hatanaka currently works as the President & Representative Director at LB Co., Ltd.







Picture Junji Hatanaka
Junji Hatanaka

Junji Hatanaka worked as an Auditor at Heiwa Paper Co., Ltd.


Picture Iwao Hatanaka
Iwao Hatanaka

Iwao Hatanaka worked as a Senior Programmer at International Business Machines Corp.
from 1986 to 2000.
He then worked as a Principal Software Architect at BEA Systems, Inc. from 2002 to 2006, followed by a position as Chief Architect at Gemvara, Inc. His last known job was as Chief Architect at n2N Commerce, Inc. from 2006 to 2007.
Hatanaka received his undergraduate degree from Cornell University in 1986 and his graduate degree from Massachusetts Institute of Technology in 2001.






Picture Takeshi Hatanaka
Takeshi Hatanaka

Takeshi Hatanaka currently works at TokurikiSeiko Co., Ltd., as Director and Kanda Tsushinki Co., Ltd., as Manager-Customer Service from 2023.




Picture Shunichiro Hatanaka
Shunichiro Hatanaka

Shunichiro Hatanaka has held director positions in multiple companies, including Administração e Gestão de Sistemas de Salubridade SA, Aguas Araucania SA, and AGS MCUK Holdings Ltd.
He currently holds director positions in all three companies.







Picture Katsumi Hatanaka
Katsumi Hatanaka

Katsumi Hatanaka is currently working as a Senior Executive Officer & GM-Sales at DAI-DAN Co., Ltd.


Picture Naoki Hatanaka
Naoki Hatanaka

Naoki Hatanaka is currently working as the Director & Senior Managing Executive Officer at Feed One Co., Ltd.
He previously worked as the Director & Manager-Livestock Feed at Nippon Formula Feed Manufacturing Co., Ltd.



Picture Kenji Hatanaka
Kenji Hatanaka

Kenji Hatanaka was the President, CEO & Representative Director of RICOH JAPAN Corp.
He was also an Outside Director at Softcreate Holdings Corp.
and a Director at Ricoh Leasing Co., Ltd.
In addition, he served as the Corporate Senior Vice President at Ricoh Co., Ltd.
in 2010 and as the President of Ricoh Sales Co., Ltd.




Picture Masataka Hatanaka
Masataka Hatanaka

Masataka Hatanaka worked as a Director & Managing Executive Officer at Nissan Chemical Corp.
and as a President & Director at Nissan Engineering Ltd.





Picture Tatsunosuke Hatanaka
Tatsunosuke Hatanaka

Tatsunosuke Hatanaka worked as an Auditor at SAKURA KCS Corp.
from 2009 to 2017.
He obtained an undergraduate degree from Chuo University in 1979.







Picture Bill Hatanaka
Bill Hatanaka

Mr. William H.
Hatanaka
is President & Chief Executive Officer at The OPSEU Pension Trust.
Mr. Hatanaka worked at Royal Bank of Canada, TD Waterhouse Canada, Inc., The Toronto-Dominion Bank, Investment Industry Association of Canada, and TD Bank US Holding Co. He also served on the board at TD Ameritrade Holding Corp.
and Canadian Centre for Diversity.







Picture Yasushi Hatanaka
Yasushi Hatanaka

Yasushi Hatanaka has held various director positions in different companies throughout his career.
His current jobs include being a Director & Senior Managing Executive Officer at Hanwa Co., Ltd., a Director at Hanwa Steel Centre (M) Sdn.
Bhd., and a Director at Hanwa Trading (Shanghai) Co., Ltd.


Picture Hajime Hatanaka
Hajime Hatanaka

Hajime Hatanaka is currently a Director at ValueCommerce Co. Ltd.
and Seven Net Shopping Co. Ltd.
He previously worked as an Outside Director at Estore Corp.


Picture Hiroshi Hatanaka
Hiroshi Hatanaka

Hiroshi Hatanaka has worked as an Outside Director at Yakiniku Sakai Holdings, Inc. since 2016 and as the President & Representative Director at M&C Consulting since 1989.



Picture Hideo Hatanaka
Hideo Hatanaka

Hideo Hatanaka has worked as a Non-Executive Director at Gyosen Hoken Chuokai since 2015.





Picture Osamu Hatanaka
Osamu Hatanaka

Osamu Hatanaka worked at KeePer Technical Laboratory Co., Ltd.
from 2001 to 2016.
He held the position of Managing Director & GM-West Japan Business from 2013 to 2016.





Picture John T. Hatanaka
John T. Hatanaka

John T.
Hatanaka
is currently working as a Senior Deputy Executive Director at Hollywood Burbank Airport.



Picture Hatanaka Kojiro
Hatanaka Kojiro

Hatanaka Kojiro has worked as a Director at Solid State System Co., Ltd.
since 2017.




Picture Yoshihiko Sogo
Yoshihiko Sogo

Yoshihiko Sogo worked as a Senior Managing Director at The Iyo Bank Ltd.

No results for this search

  1. Stock Market
  2. Advanced search
  3. Yoshihiko Hatanaka